Signature for Predicting Extreme Resistance the integrated data of the two datasets with 94 responders and 21 extremely resistant samples identified from RD patients, the former had significantly longer DRFS than the latter (P < 0.01; HR = 2.22; 95% CI = 1.26-3.90). In summary, our signature could effectively identify patients who completely respond to PAC NAC, as well as cases of extreme resistance, which can assist decision-making on the clinical therapy for these patients.
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a high recurrence rate and mortality. There is no effective treatment for HCC and the molecular mechanisms of HCC are still not fully understood. To identify the potential biomarkers in the carcinogenesis and progression of HCC, microarray datasets GSE101685, GSE121248, GSE38941, GSE62232 and GSE87630 were downloaded from Gene Expression Omnibus (GEO) database. Screening of differential expressed genes (DEGs), and functional enrichment analyses were performed. The protein-protein interaction network (PPI) were constructed and significant module genes and hub genes were identified using STRING and Cytoscape. 149 DEGs were screened, including 114 down-regulated genes and 35 up-regulated genes. Fifteen hub genes were identified and biological process analysis revealed that these genes were mainly enriched in cell cycle, oocyte meiosis and protein binding. Survival analysis and co-expression network analysis showed that TOP2A, TPX2, RACGAP1 and PTTG1 may be involved in the carcinogenesis, invasion or recurrence of HCC. In conclusion, the present study may help us understand the molecular mechanisms underlying the carcinogenesis and progression of HCC, and provide candidate targets for diagnosis and treatment of HCC.
Key words: Hepatocellular carcinoma; Differentially expressed genes; Protein-protein interaction; Bioinformatics; Microarray
Citation Format: Xianzhang Zeng, Lu Ao, Xinjian Lin, Xu Lin, Wannan Chen. Bioinformatics analysis for hub genes and pathways in hepatocellular carcinoma [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 4382.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.